glp-1 receptor agonists for weight loss Frontiers List of GLP-1 Receptor Agonists
Description
A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity
Zada G, Tirosh A, Kaiser UB, Laws ER, Woodmansee WW
Conversely, among GLP-1RA non-users with HbA1c 7.5% (957 of 3747
Some also raise questions and concerns about compounded options, highlighting the uncertainty people feel when affordability becomes a treatment barrier
K.TurchinA.PatelH
Accepted 2021-4-28
